Skip to main content
Clinical Trials/NCT05113563
NCT05113563
Completed
Not Applicable

Investigation of TEST (Transcranial Electric Stimulation Therapy) for Chronic Pain

New York State Psychiatric Institute1 site in 1 country6 target enrollmentJanuary 2, 2023
ConditionsChronic Pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Pain
Sponsor
New York State Psychiatric Institute
Enrollment
6
Locations
1
Primary Endpoint
Feasibility Will be Assessed by the Percent of Participants Who Complete
Status
Completed
Last Updated
last year

Overview

Brief Summary

The goal in this study is to investigate TEST (Transcranial Electric Stimulation Therapy) for chronic pain. It requires an inpatient stay on our research unit of about a month. The study is designed to address the cognitive and emotional aspects of chronic pain and other conditions that often accompany this disorder, such as major depression or drug use.

Detailed Description

This project proposes to investigate the feasibility of TEST in subjects with chronic pain. This will be an open-label study where subjects (n=12) are administered 8-10 sessions of TEST over 4 weeks. Measurements of pain, mood, and memory will be obtained before and after the sessions. The hypothesis is that TEST will be feasible and tolerable in this population.

Registry
clinicaltrials.gov
Start Date
January 2, 2023
End Date
January 17, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Diana Martinez

Clinical Professor in Psychaitry

New York State Psychiatric Institute

Eligibility Criteria

Inclusion Criteria

  • adults (ages 22 to 60) who understand all procedures and have the ability to provide informed consent, with a score on the Mini-Mental Status Exam of at least 24;
  • participants experiencing chronic pain, with ongoing pain symptoms, and score on the Brief Pain Inventory of \> 5 on question #3 (which asks about maximal pain in the past 24 hours) or \> 5 on question #5 (which asks about average pain in the past 24 hours);
  • a diagnosis of chronic postoperative pain, low back pain, musculoskeletal pain, fibromyalgia, visceral pain or neuropathic pain, including complex regional pain syndrome or peripheral neuropathy;
  • no significant changes in pain medications for at least one month prior to study entry.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Feasibility Will be Assessed by the Percent of Participants Who Complete

Time Frame: 4 weeks

Feasibility will be assessed by the percent of participants start study procedures and complete these

Study Sites (1)

Loading locations...

Similar Trials